Author:
Colleoni M.,Zarieh D.,Gelber R.D.,Viale G.,Luini A.,Veronesi P.,Intra M.,Galimberti V.,Renne G.,Goldhirsch A.
Reference21 articles.
1. Fisher B, Gunduz N, Saffer E A. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastasis. Cancer Res 1983; 43:1488–1492.
2. Fisher B, Gunduz N, Coyle J et al. Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res 1989; 49: 1996–2001.
3. Mauriac L, MacGrogan G, Avril A et al. Neoadjuvant chemo-therapy for operable breast carcinoma larger than 3cm: a unicentre randomized trial with a 124-month median follow-up Institut Bergonie Bordeaux Groupe Sein (IBBGS). Ann Oncol 1999; 10: 47–52.
4. Semiglazov V F, Topuzov E E, Bavli J L et al. Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radio-therapy alone in stage IIb-IIIa breast cancer. Ann Oncol 1994; 5: 591–595.
5. Scholl S M, Pierga J Y, Asselain B et al. Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. Eur J Cancer 1995; 31A: 1969–1975.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献